COVID-19 Pandemic and Vaccine Imperialism

被引:0
作者
Seretis, Stergios A. [1 ]
Mavroudeas, Stavros D. [2 ]
Tanik, Feride Aksu [3 ]
Benos, Alexios [4 ]
Kondilis, Elias [4 ]
机构
[1] Aristotle Univ Thessaloniki, Dept Med, Sch Med, Univ Campus, Thessaloniki, Greece
[2] Pante Univ Social & Polit Sci, Social Policy, 136 Syggrou Ave, Athens 17671, Greece
[3] Ege Univ, Fac Med, Dept Publ Hlth, Izmir, Turkiye
[4] Aristotle Univ Thessaloniki, Sch Med, Fac Hlth Sci, Thessaloniki, Greece
关键词
COVID-19; pandemic; vaccination; vaccination inequalities; intellectual property rights; vaccine imperialism; HEALTH; GLOBALIZATION; ECONOMY; FUTURE;
D O I
10.1177/04866134241282107
中图分类号
F [经济];
学科分类号
02 ;
摘要
The COVID-19 pandemic revealed and exacerbated the global inequalities regarding the availability and access to vaccines. Many terms have appeared in the academic literature ("vaccine colonialism," "vaccine nationalism," "vaccine apartheid") trying to capture and interpret these inequalities, failing in most cases to realistically explain the upstream causes of the observed injustices. A Marxist perspective on the contrary emphasizes the structural causes of inequalities in capitalism and attributes them to the existence of economic exploitation. "Vaccine imperialism," which refers to the control that advanced industrialized countries exert on the development, production, and distribution of vaccines at the expense of less-developed economies, can describe and explain in a more realistic way the observed inequalities during the pandemic. Our study proposes a circuit of vaccine imperialism that explains how economic imperialist exploitation takes place via transfers of value from less-developed economies (vaccine recipient countries) to imperialist economies (vaccine producing and patent holder countries) using four different channels: (a) protection of intellectual property (IP) rights (patents), (b) earnings from royalty payments for the use of vaccines (monopolistic prices and profits), (c) exercise of monopoly power on the production and distribution of vaccines (control over the quantity of vaccines supplied, exclusion of competitors through vaccine licensing), and (d) public debt servicing.
引用
收藏
页码:9 / 29
页数:21
相关论文
共 100 条
[61]  
Mavroudeas Stavros., 2021, Impacts of COVID-19 on Societies and Economies, P37
[62]  
Mavroudeas Stavros., 2018, Journal of Economics and Business, V21, P43
[63]  
Mavroudeas Stavros., 2019, Globalisation and Public Policy, P13
[64]   Is it time to nationalise the pharmaceutical industry? [J].
Mazzucato, Mariana ;
Li, Henry Lishi ;
Darzi, Ara .
BMJ-BRITISH MEDICAL JOURNAL, 2020, 368
[65]   Public financing of innovation: new questions [J].
Mazzucato, Mariana ;
Semieniuk, Gregor .
OXFORD REVIEW OF ECONOMIC POLICY, 2017, 33 (01) :24-48
[66]  
Meevi Iza Razija., 2021, International and Comparative Law Review, V21, P43
[67]   THE LEGALITY OF A TRIPS WAIVER FOR COVID-19 VACCINES UNDER INTERNATIONAL INVESTMENT LAW [J].
Mercurio, Bryan ;
Upreti, Pratyush Nath .
INTERNATIONAL & COMPARATIVE LAW QUARTERLY, 2022, 71 (02) :323-355
[68]   Political restraint of the market and levels of criminal homicide: A cross-national application of institutional-anomie theory [J].
Messner, SF ;
Rosenfeld, R .
SOCIAL FORCES, 1997, 75 (04) :1393-1416
[69]   Tanzania's COVID-19 vaccination strategy: lessons, learning, and execution [J].
Mfinanga, Sayoki Godfrey ;
Gatei, Wangeci ;
Tinuga, Florian ;
Mwengee, William Mngupe Patrick ;
Yoti, Zabulon ;
Kapologwe, Ntuli ;
Nagu, Tumaini ;
Swaminathan, Maheshi ;
Makubi, Abel .
LANCET, 2023, 401 (10389) :1649-1649
[70]  
Murray Robin., 2013, The Multinational Enterprise